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ABSTRACT A central step in vertebrate visual transduc-
tion is the rapid drop in cGMP levels that causes cGMP-gated
ion channels in the photoreceptor cell membrane to close. It has
long been a puzzle that the cGMP phosphodiesterase (PDE)
whose activation causes this decrease contains not only catalytic
sites for cGMP hydrolysis but also noncatalytic cGMP binding
sites. Recent work has shown that occupancy of these noncat-
alytic sites slows the rate ofPDE inactivation. We report here
that PDE activation induced by activated transducin lowers the
cGMP binding afnit for noncatalytic sites on PDE and
accelerates the disation of cGMP from these sites. These
sites can exist in three states: gh affinity (Kd =60 nM) for the
nonactivated PDE, intermediate affinity (Kd 180 nM) when
the enzyme is activated in a complex with trasducin, and low
aMnity (Kd > 1 FM) when transducin physically removes the
inhibitory subunits of PDE from the PDE catalytic subunits.
Activation of PDE by htrnducin causes a 10-fold increase in
the rate ofcGMP discation from one of the two noncatalyc
sites; physical removal of the inhibitory subunits from the PDE
catalytic subunits further accelerates the cGMP disiation
rate from both sites >50-fold. Because PDE molecules lacking
bound cGMP inactivate more rapidly, this suggests that a
prolonged cGMP decrease may act as a negative feedback
regulator to generate the faster, smaller photoresponses char-
acteristic of liht-adapted photoreceptors.
The chain ofevents responsible for visual excitation in retinal
rod photoreceptors is well documented (reviewed in refs.
1-4). Photoexcitation of rhodopsin results in activation of
transducin, the heterotrimeric guanine nucleotide-binding
protein (G protein) of photoreceptor cells, which then binds
and activates its effector enzyme, cGMP phosphodiesterase
(PDE). The acceleration of PDE activity results in a drop in
the cytoplasmic concentration of cGMP, which causes the
closure of cGMP-gated plasma membrane cationic channels
and cell hyperpolarization. The visual excitation cascade is
inactivated by several processes that serve to restore the
dark-adapted condition. These events include phosphoryla-
tion ofrhodopsin by rhodopsin kinase and binding of arrestin
to phosphorylated rhodopsin, hydrolysis of GTP on trans-
ducin by its intrinsic GTPase activity, restoration of PDE
inhibition by its y subunits, and resynthesis of cGMP by
guanylate cyclase.
Nonactivated rod PDE is a heterotetramer consisting of
two similar a and 13 catalytic subunits and two identical fy
subunits which serve as a protein inhibitor of the enzyme
(reviewed in refs. 2, 5, and 6). Each of the a and 1 subunits
contains one catalytic site forcGMP hydrolysis as well as one
or, probably, two noncatalytic cGMP binding sites (Fig. 1A;
refs. 7-10). The inhibitory constraint of the PDE y subunits
is released when activated transducin a subunit (a-GTP)
binds to the PDE heterotetramer and either displaces PDE Y
subunits or causes their physical removal from the PDE
catalytic subunits (11-17). PDE inactivation and reassocia-
tion of the holoenzyme (afPy2) results when transducin be-
comes inactivated following GTP hydrolysis.
PDE (18, 19), and specifically its inhibitory 'y subunit (18,
20), can act as a GTPase-activating protein to accelerate the
hydrolysis of GTP bound to activated transducin. Hence,
PDE appears capable of regulating its activated lifetime.
Furthermore, studies with amphibian rod outer segments
(ROS) showed that the mechanism of PDE activation by
transducin, as well as the extent of GTPase stimulation,
depends on the state of occupancy of cGMP on noncatalytic
PDE binding sites (12, 18). When the sites are occupied by
cGMP, transducin activation results in formation of a com-
plex of at-GTP and activated PDE ap3'y holoenzyme (Fig.
1B); in this case, the inhibitory y subunits are displaced from
their site of inhibition but do not dissociate from the catalytic
a(3 subunits. Transducin GTPase activity in this case is
relatively slow, and PDE stays active longer. When the
cGMP binding sites are empty, activated transducin physi-
cally removes PDE 'y subunits from the catalytic subunits
(Fig. 1C), and the y subunits now maximally accelerate
GTPase activity. In this model, binding of cGMP to the
noncatalytic cGMP binding sites serves to regulate the life-
time of activated transducin, and hence the lifetime of
activated PDE. This negative feedback scheme could repre-
sent an element of the biochemical mechanism of photore-
ceptor light adaptation wherein sustained photoactivation of
the transduction cascade results in smaller and faster photo-
responses to flashes of light.
To examine this hypothesis, we have studied the dynamics
of cGMP binding and dissociation at the PDE noncatalytic
sites to determine (i) whether this binding occurs in the
physiological range of cGMP concentration changes, (ii)
whether the cGMP dissociation occurs on the time scale of
photoreceptor light adaptation, and (iii) whether PDE y
subunits can directly influence cGMP binding to PDE non-
catalytic sites. We find that PDE activation lowers the
binding affinity of cGMP and accelerates the dissociation
kinetics of these sites via changes in the association of the
PDE y subunit to the catalytic subunits. These data support
a model in which a sustained decrease in cGMP concentra-
tion that occurs during continuous illumination will promote
the release of bound cGMP from noncatalytic sites on acti-
vated PDE. The time scale of cGMP dissociation from PDE,
tens of seconds, correlates with the onset of some aspects of
rod light adaptation observed in physiological studies.
Abbreviations: PDE, cGMP phosphodiesterase; ROS, rod outer
segment(s); GTP[-S], guanosine 5'-[ythio]triphosphate; a,, acti-
vated a subunit of transducin.
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FIG. 1. Model of the reciprocal regulation of noncatalytic cGMP binding sites, PDE y subunits, and catalytic activity of rod photoreceptor
PDE. (A) In the dark, nonactivated PDE consists of two inhibitory y subunits which inhibit catalytic activity at the active site (V-shaped notch)
on the a and P subunits; the regulatory cGMP (cG) binding sites are represented in their highest-affinity conformation. (B) Activated transducin
a subunit (a4-GTP) partially displaces the PDEy subunits, completely relieving inhibition of catalysis and lowering somewhat the cGMP binding
affinity at noncatalytic sites. (C) The activated PDE aig dimer has the same catalytic activity as in B, but the complete dissociation of y subunits
results in a large reduction in cGMP binding affinity at regulatory sites (see text).
MATERIALS AND METHODS
Materials and Solutions. [8-3H]cGMP was purchased from
DuPont/NEN and Percoll from Pharmacia LKB. Zaprinast
was a gift of May and Baker (Dagenham, U.K.). Other
chemicals were obtained from Sigma. The Ringer's solution
used to isolate rod photoreceptors contained 105 mM NaCl,
2mM KCl, 2mM MgCl2, 1 mM CaCl2, and 10 mM Hepes (pH
7.5). The "intracellular" medium used in all experiments
contained 77 mM KC1, 35 mM NaCl, 2.0mM MgC12, 1.0mM
dithiothreitol, 1.0 mM CaCl2, 1.16 mM EGTA, 10 mM Hepes
(pH 7.5, pCa 6.7).
Preparation of ROS Membranes. Live bullfrogs (Rana
catesbeiana or Rana grylio) were purchased from commer-
cial sources and maintained with feeding on a 12-hr light,
12-hr dark cycle at least 2 weeks before use. Isolation ofROS
was done in the dark under infrared illumination, as described
(21). In brief, animals were decapitated, and retinas were
removed, placed into Ringer's solution containing 5% Per-
coll, and shaken gently to detach ROS. The isolated ROS
were purified on a Percoll gradient. Intact ROS were washed
free of Percoll in Ringer's solution and then disrupted in a
motorized Potter-Elvehjem homogenizer (creating a mem-
brane suspension with no structure detectable by light mi-
croscopy). The ROS membrane preparation was incubated
for w30 min at room temperature to deplete endogenous
nucleotides, including bound cGMP (22). The rhodopsin
concentration was determined spectrophotometrically (23).
Preparation of Nonactivated PDE, a-Guanosine 5'-[ythio]
Triphosphate (GTP[-ySJ)-Activated PDE, and Activated
PDEaII Dimers. The finding that PDE is the only protein in
amphibian ROS which binds cGMP with high affinity (i.e., in
the submicromolar range; refs. 7 and 22) permitted us to
study the dynamics ofPDE noncatalytic sites under relatively
physiological conditions in unfiactionated ROS membrane
preparations. We verified this premise by purifying amphib-
ian PDE to homogeneity (12) and determining that the
high-affinity cGMP binding could be solely ascribed to PDE
[apparent equilibrium dissociation constant (Kd) = 60 nM,
maximum site density (B..) 2 cGMP per PDE holoen-
zyme; V.Y.A. and R.H.C., unpublished observations]. Low-
er-affinity cGMP binding sites present in ROS (22) will not
bind [3H]cGMP to any significant extent under the experi-
mental conditions'(<1 puM cGMP) used in this study, nor
would they be easily detected by the filter binding assay used
for our cGMP binding determinations.
The PDE content of ROS membrane preparations was
calculated by assuming a ratio for PDE/rhodopsin of 1:270
(24). To ensure that ROS membrane preparations contained
sufficient PDE y subunits to maintain nonactivated PDE in its
heterotetrameric form (a3y2), -1 additional PDE 'y subunit
per PDE molecule was routinely added to ROS membrane
preparations before cGMP addition. To prepare PDE acti-
vated by transducin, a poorly hydrolyzable analog of GTP,
GTP[(], was added to illuminated ROS membranes in suf-
ficient amounts to activate all transducin (=2-fold molar
excess).
Membranes containing PDE depleted of most of the y
subunits were prepared as described (12, 15). In brief,
illuminated ROS suspensions containing 20 IAM rhodopsin
were incubated for 1 min with 10 pM GTP in intaellular
medium and then diluted 10-fold with the same medium and
immediately centrifuged at 40,000 x g. After this procedure
most of the PDE 'y subunit was found in the supernatant in a
soluble complex with transducin. The membrane pellet was
washed once to remove the residual GTP and finally resus-
pended in a Potter-Elvelijem homogenizer. A combination of
PDE y quantitation by the Western blot analysis along with
direct determinations of PDE hydrolytic activity (described
in detail in ref. 12) showed that 70-80%o of the PDE in this
preparation was present as the af3 dimer, while the rest
retained one or two y subunits.
Preparation of Recombinant PDE y Subunit. Recombinant
PDE y subunit was purified by a combination of cation-
exchange and reverse-phase chromatography (25) from Esch-
erichia coli BL21(DE3) transformed with an expression plas-
mid containing a synthetic PDE -y-subunit gene. The gene was
originally prepared as a fusion protein (25). The coding
sequence for PDE 'y subunit was subcloned into the expres-
sion vector pET-11a (Novagen) by J. Sondek (Yale Univer-
sity). The concentration of PDE 'y subunit was determined
spectrophotometrically at 280 nm by using a molar extinction
coefficient of 7100.
Filter Binding Assay of cGMP Binding. Nucleotide-
depleted ROS membrane preparations described above were
mixed with an equal volume of intracellular medium contain-
ing [3H]cGMP and a type V-specific inhibitor of PDE, zap-
rinast (26). Zaprinast was prepared as a 400 mM stock
solution in 1-methyl-2-pyrrolidinone and diluted to the final
concentration of 1 mM in the intracellular medium. Simul-
taneous measurements of PDE activity during the filter
binding assay (12, 22) showed that <10% of the [3H]cGMP
was hydrolyzed under all experimental conditions. Zaprinast
(1 mM) was found to have no discernible effect on cGMP
binding to PDE noncatalytic sites (K. R. McCarthy and
R.H.C., unpublished observations). For experiments in
which GTP[yS] was used, we ascertained that undetectable
amounts ofcGMP were being synthesized from GTP[yS] via
endogenous guanylate cyclase activity in ROS.
For equilibrium binding measurements, incubations pro-
ceeded for 2 min at room temperature, and then 25-pl
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portions were added to prewet nitrocellulose filters (Milli-
pore, HAWP 025) on a vacuum manifold system. The filters
were then rinsed with three 1-ml portions of ice-cold intra-
cellular medium. Sample application and filter washing were
completed within 4 sec. Nonspecific binding (<1% of the
total dpm) was determined as described (22). Filter-bound
radioactivity was measured in a scintillation counter and the
data were analyzed with the nonlinear, weighted least-
squares curve-fitting programs EBDA, LIGAND, and KINETIC
(27) and SIGMAPLOT (Jandel, Corte Madera, CA).
RESULTS
To characterize the noncatalytic sites in both inactive and
activated PDE, we used three different ROS preparations
(see Materials and Methods) which are shown schematically
in Fig. 1. The first is a suspension of homogenized ROS
containing nonactivated PDE holoenzyme (Fig. 1A). The
second preparation is the same ROS preparation to which
GTP[-yS] has been added to persistently activate transducin.
In the presence of cGMP the activated PDE heterotetramer
exists in a complex with two molecules of a4-GTP[FyS] (Fig.
1B). The third preparation consists of homogenized ROS
suspensions depleted of most of the PDE 'y subunits; hence,
PDE exists primarily as the activated a,8 dimer (Fig. 1C).
PDE Activation Results in a Decrease in the Affinity of
Nonca tic cGMP Binding Sites. Equilibrium binding of
cGMP to nonactivated PDE exhibited a Kd of 57 ± 7 nM
(mean ± SD) and a B.. of 0.006 ± 0.001 mol of cGMP per
mol of rhodopsin (Fig. 2, top curve), in agreement with a
previous estimate (22). The maximum amount of cGMP
binding is equivalent to 1.6 ± 0.3 mol ofcGMP bound per mol
of PDE holoenzyme, consistent with the binding stoichiom-
etry of 2 mol of cGMP per mol of holoenzyme observed in
bovine rod PDE (9).
Activation of PDE by a4-GTP[,yS] reduced the apparent
binding affinity by a factor of 3 (Fig. 2, middle curve), with
only a minor reduction in BEm,,. This particular experiment
does not represent a true equilibrium binding situation,
because addition of increasing amounts of cGMP to a ROS
preparation containing GTP[yS] should enhance binding of
PDE y subunits to PDE a,4 dimers, which in turn should
enhance cGMP binding affinity at noncatalytic sites on PDE.
When PDE a(3 dimers were prepared by physical removal
of 70-80% of the inhibitory y subunit, an =80%o reduction in
the maximum extent of [3H]cGMP binding was observed
(Fig. 2, bottom curve). The high-affinity cGMP binding sites
had not been destroyed, since the addition ofexogenous PDE
y subunit restored high-affinity cGMP binding in a dose-
dependent manner (see below). Rather, we conclude that the
binding affinity of these sites has been reduced beyond the
range of detection of the filter binding assay (Kd > 1 pLM).[Low-affinity cGMP binding in this preparation could be
detected by a centrifugal separation technique (22, 28), but
the Kd in this case was too high (>7 pM) for reliable
determinations.] These results are consistent with an earlier
observation of a reduction of cGMP binding upon activation
of frog PDE (8). The small amount of high-affinity cGMP
binding observed in the bottom curve of Fig. 2 is consistent
with residual PDE holoenzyme present in this PDE a(3 dimer
preparation (see Materials and Methods).
PDE y Subunits Regulate the Big Affinity of cGMP to
Noncatalytic Sites. The above results suggest a reciprocal
relationship between binding of PDE y subunit to PDE ac
dimers and the binding affinity of cGMP to the noncatalytic
binding sites of PDE. To test this possibility, we first pre-
pared ROS depleted of PDE Y subunits to obtain a prepara-
tion composed primarily of PDE a,4 dimers. Addition of
increasing amounts of PDE y subunits to this preparation
resulted in a progressive restoration of high-affinity cGMP
0
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FIG. 2. Affinity of cGMP for noncatalytic binding sites on PDE
is reduced by PDE activation. Frog ROS membrane preparations (11
MM rhodopsin, 41 nM PDE) containing nonactivated PDE supple-
mented with 40 nM exogeious PDE y subunits (top curve), PDE
activated by illumination in the presence of GTPyS] (middle curve),
or PDE activated by physical removal of the y subunits (bottom
curve) were incubated with various concentrations of [3H]cGMP,
and the amount ofboundcGMP [mol permol ofrhodopsin (Rho)] was
determined by the filter binding assay. Symbols are data from one
representative experiment, whereas the hyperbolic curves represent
a model that assumes a single class of independent, noninteracting
binding sites. For the nonactivated PDE holoenzyme (top curve), the
Kd was57 ± 7nM (mean ± SD, n = 8) and theBm. was 0.006 ± 0.001
mol of cGMP per mol of rhodopsin (or 1.6 ± 0.3 mol of cGMP per
mol of PDE). For transducin-activated PDE (middle curve), the data
are consistent with a single class ofbinding sites with an apparent Kd
of 180 ± 30 nM (n = 6) and a similarBm = 0.005 ± 0.001 mol of
cGMP per mol of rhodopsin. (Note that this is not truly an equilib-
rium binding situation; see text.) For membranes depleted ofPDE 'y
subunits (bottom curve), -80%o of the sites originally present have
lost the ability to bind cGMP at submicromolar concentrations due
to a large decrease in binding affinity. The high-affinity binding sites
that were detected (Kd = 71 nM,Bm -0.001 mol ofcGMP per mol
of rhodopsin; n = 3) are consistent with =20%6 ofPDE holoenzyme
remaining in this membrane preparation because of incomplete
extraction ofPDE vsubunit from the ROS membranes (see Materials
and Methods).
binding (Fig. 3). Full restoration of high-affinity cGMP bind-
ing was observed when two to three PDE ysubunits perPDE
ac8 dimer were added to this activated PDE preparation.
Because each catalytic subunit has one high-affinity noncat-
alytic cGMP binding site, this indicates that binding ofPDE
'y subunit to both catalytic subunits is necessary to com-
pletely convert both noncatalytic sites from low to high
affinity.
PDE Activation Accelerates cGMP Di tion from the
Noncatalytic Sites. Since the cytoplasmic cGMP concentra-
tion in rod photoreceptors is estimated to be 1-5 pM and to
decrease upon illumination to levels similar to those studied
in Fig. 2 (1), one physiological consequence ofphotoreceptor
illumination may be a net dissociation of cGMP from non-
catalytic binding sites on PDE. However, the extent ofcGMP
dissociation will most likely depend on the (i) duration of the
light stimulus, (ii) the state of activation ofPDE, and (iii) the
dissociation rate constant for cGMP release from PDE non-
catalytic sites. To determine whether cGMP dissociation
occurred on a physiological time scale, we first equilibrated
the PDE preparations depicted in Fig. 1 with micromolar
levels of [3H]cGMP to occupy noncatalytic binding sites and
Neurobiology: Cote et al.
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FIG. 3. Addition of PDE 'y subunit restores high-affinity binding
of cGMP to the noncatalytic sites of the PDE a,8 dimer. PDE
-y-depleted membranes containing 10 AM rhodopsin (37 nM PDE)
were incubated with various concentrations of recombinant bovine
PDE y subunit prior to addition of 1 pM [3H]cGMP. High-affinity
cGMP binding was quantitated by the filter binding assay. The
different symbols represent the data from three experiments. The
hyperbolic saturation curve, originating at 27% of maximal binding,
has Ki/2 = 44 nM PDE y.
then monitored the rate of its displacement after adding an
excess ofunlabeled cGMP. PDE activation increased the rate
of [3H]cGMP dissociation from minutes to seconds (Fig. 4).
Nonactivated PDE holoenzyme released [3H]cGMP in a
slow, monotonic fashion (t112 - 5.8 min; Fig. 4, top curve).
The PDE holoenzyme in a complex with activated transducin
showed accelerated, biphasic dissociation kinetics (Fig. 4,
middle curve), consistent with two classes of binding sites
present in approximately equal concentration but differing
10-fold in dissociation rates (t1l2 = 25 sec and 4.4 min). This
result suggests that the high-affinity noncatalytic cGMP
binding sites on PDE a and ( subunits are not equivalent, and
may explain why the decrease in total cGMP concentration
in intact photoreceptors is always <50% during the first few
tens of seconds of continuous illumination (29-32). The
dissociation of bound cGMP from the PDE. af3 dimer (Fig. 4,
bottom curve) was accelerated >50-fold compared with
nonactivated PDE holoenzyme. Approximately 80%o of the
total cGMP dissociated more rapidly than the time resolution
of our method (=4 sec); the 20%6 of tie cGMP dissociating
with a slow rate may be attributed to the fraction of inactive
PDE still retaining y subunits.
DISCUSSION
Our observations can be summarized by the model depicted
in Fig. 1. In the absence of illumination, PDE is not activated
and the noncatalytic cGMP binding sites are present in their
highest-affinity conformation (Fig. 1A). Tight binding of
cGMP ensures tight binding of the inhibitory 'y subunits and
the low basal level ofPDE catalytic activity characteristic of
dark-adapted photoreceptors (12). The binding affinity for
cGMP at the noncatalytic sites is lowered severalfold when
activated transducin partially displaces PDE y subunits from
the PDE catalytic subunits (Fig. 1B); under this condition, we
predict the relatively rapid dissociation of half of the bound
cGMP on PDE. When PDE y completely dissociates from
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FIG. 4. Rate of cGMP dissociation from the PDE noncatalytic
binding sites is accelerated by PDE activation. ROS membrane
preparations (20 pM rhodopsin, 74 nM PDE) containing either
nonactivated PDE orPDE act dimer were incubated for 2 min at room
temperature with 1 or 10 pM [3H]cGMP, respectively, to occupy the
noncatalytic sites. Dissociation of [3H]cGMP was initiated at time
zero by addition of 1 mM nonradioactive cGMP (top and bottom
curves) or 1 mM cGMP plus 20 uM GTP[yS] (middle curve). The
amount of bound PH]cGMP was determined by the filter binding
assay. The data points are averaged from three experiments, and the
curves represent the fit of these data to either a single exponential
decay process (PDE holoenzyme: ti/2 = 5.8 min) or a double
exponential decay process (PDE holoenzyme plus a-GTP[v6]:
Bxl = 58%, ti/2 = 4.4 min;Bm2 = 42%, ti/2 = 25 sec). For the case
of the PDE a(3 preparation, the rapid component (-77% of total
bound cGMP) was too fast to monitor, whereas the slower compo-
nent (-23% of total bound cGMP, t/; - 1 min) may represent
contamination of this PDE at preparation with a small amount of
PDE associated with one or two y subunits.
reduced, and any bound cGMP is expected to dissociate very
rapidly from both noncatalytic binding sites on the a43 dimer.
This reciprocal regulation of PDE by its inhibitory 'y
subunit and by cGMP may play a role in light adaptation of
amphibian rod photoreceptors. Consider first the response of
a dark-adapted rod photoreceptor to a flash oflight. Transient
activation of PDE (from A to B in Fig. 1) will cause a
temporary drop in cytoplasmic cGMP concentration but little
dissociation of bound cGMP on the time scale of the flash
response. Because cGMP remains bound to the noncatalytic
sites, PDE y subunits remain bound to PDE a(3 (12), and
hence transducin activation is relatively long-lived (18). This
accounts for the larger, slower photoresponses characteristic
ofdark-adapted rod photoreceptors. Continuous illumnation
sufficient to activate most of the PDE will cause a sustained
drop in cytoplasmic cGMP levels. In response to this cGMP
decrease, we predict a gradual transition ofPDE fromB to C
(Fig. 1) as dissociation of bound cGMP occurs over tens of
seconds. The form in Fig. 1C inactivates more rapidly than
that in Fig. 1B because the ability of dissociated PDE y
subunit to activate transducin GTPase is more pronounced
than that ofPDE holoenzyme (18). As a result the number of
activated PDE molecules is expected to decrease with sus-
tained continuous illumination, and partial restoration offree
cytoplasmic cGMP levels and of the cGMP-gated ionic con-
ductance is predicted. If this light-adapted photoreceptor is
now exposed to a flash of light, a smaller and faster photo-
response is predicted; the amplitude and kinetics of the flash
response might be determined by the relative abundance in
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this photoreceptor of the three forms ofPDE depicted in Fig.
1. Thus, we propose that the noncatalytic cGMP-binding sites
on PDE serve as a sensor of the level of background illumi-
nation in order to regulate desensitization of the cGMP
transduction pathway. This hypothesis about the role of
cGMP in photoreceptor light adaptation is consistent with
electrophysiological evidence which demonstrates a gradual
acceleration of the recovery of the photoresponse when
amphibian rod photoreceptors are exposed to continuous
illumination on the time scale of tens of seconds (33, 34). Our
proposed mechanism is distinct from, but complementary to
those aspects of light adaptation that are believed to be
regulated by calcium (reviewed in refs. 1-4).
It is important to note that our model is based on two
assumptions. The first is that the GTPase activity of trans-
ducin, rather than some other mechanism (see ref. 35),
determines the rate of PDE inactivation during the recovery
phase of the photoresponse. The second assumption is that
the reassociation ofPDE ywith PDE an occurs more rapidly
than the transducin GTPase reaction. Recent experiments
supporting these assumptions have demonstrated that the
rates ofPDE turnoff and transducin GTPase in disrupted frog
ROS correlate well both in the presence and in the absence
of cGMP binding in the PDE noncatalytic sites (V.Y.A.,
C. L. Dumke and M.D.13., unpublished work).
One interesting point which is not addressed by the exper-
iments in this paper is the exact sequence of events which
occur during the transition from B to C in Fig. 1. Our data do
not allow us to distinguish whether cGMP dissociation from
noncatalytic sites precedes or follows the dissociation of the
at-GTP-PDE y complex from PDE an.
The results shown in Fig. 4 for at-GTP [yS]-activated PDE
indicate that the two noncatalytic cGMP binding sites on
PDE do not dissociate equally rapidly under certain condi-
tions. We cannot distinguish at present whether the cGMP
binding sites on the a and (3 subunits are intrinsically different
or whether dissociation of one cGMP molecule from the
holoenzyme allosterically induces a reduced cGMP dissocia-
tion from the other noncatalytic site. The observation that the
total cellular cGMP concentration seldom drops below 50%6
of its dark-adapted value even after prolonged illumination
(29-32), along with the fact that the high-affinity cGMP site
density in ROS is practically equal to the total cGMP con-
centration, suggests that one noncatalytic cGMP binding site
on PDE may tightly bind half of the total cellular cGMP even
after sustained photoreceptor stimulation. This suggests that
dissociation of only one cGMP molecule from transducin-
activated PDE may be sufficient to induce the GTPase-
activating activity of PDE.
Our results demonstrate that the dynamics ofcGMP bind-
ing to noncatalytic binding sites on PDE occur over a range
ofcGMP concentrations similar to the predicted cytoplasmic
free cGMP levels in living rod photoreceptors. Furthermore,
while changes in the site occupancy upon PDE activation are
too slow to be involved in visual excitation, the dissociation
kinetics do correlate with some aspects oflight adaptation (as
judged from electrophysiological studies; refs. 33 and 34).
Our results, combined with previous observations (12, 18,
36), suggest that the light-induced decrease in cGMP levels in
amphibian photoreceptors feeds back on the transduction
cascade to decrease the lifetime of activated PDE and thus
causes desensitization of visual excitation during prolonged
stimulation. The control of cGMP concentration in retinal
photoreceptors by means of allosteric interaction with its
effector enzyme may represent a desensitization mechanism
that may be of general importance in other signal transduc-
tion systems employing second messengers.
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